These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 37861025)

  • 1. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
    Kumar S; Mahajan A; Ambatwar R; Khatik GL
    Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer's Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress.
    Singh K; Kaur A; Goyal B; Goyal D
    ACS Chem Neurosci; 2024 Jul; 15(14):2545-2564. PubMed ID: 38979773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.
    Das S; Basu S
    Curr Top Med Chem; 2017; 17(27):3017-3061. PubMed ID: 28685694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis.
    Nozal V; García-Rubia A; Cuevas EP; Pérez C; Tosat-Bitrián C; Bartolomé F; Carro E; Ramírez D; Palomo V; Martínez A
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19344-19354. PubMed ID: 34169618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
    Lin LF; Luo HM
    Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
    Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Song Q; Cao Z; Deng Y; Zhang L
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Multitarget Strategies for Membrane Protection in Alzheimer's Disease.
    Zambrano P
    ACS Chem Neurosci; 2023 Nov; 14(22):3972-3974. PubMed ID: 37874335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation.
    Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review.
    Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA
    Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease.
    Zhang X; He X; Chen Q; Lu J; Rapposelli S; Pi R
    Bioorg Med Chem; 2018 Feb; 26(3):543-550. PubMed ID: 29310862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
    Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
    Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
    Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
    Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
    George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
    Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
    Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.
    Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F
    Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.